163 related articles for article (PubMed ID: 26675163)
1. Pancreatic Cancer: Clinical Significance of Biomarkers.
Ohuchida K; Ohtsuka T; Mizumoto K; Hashizume M; Tanaka M
Gastrointest Tumors; 2013 Sep; 1(1):33-40. PubMed ID: 26675163
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biology.
Zhan HX; Zhou B; Cheng YG; Xu JW; Wang L; Zhang GY; Hu SY
Cancer Lett; 2017 Apr; 392():83-93. PubMed ID: 28189533
[TBL] [Abstract][Full Text] [Related]
3. The clinical utility of biomarkers in the management of pancreatic adenocarcinoma.
Jazieh KA; Foote MB; Diaz LA
Semin Radiat Oncol; 2014 Apr; 24(2):67-76. PubMed ID: 24635863
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of pancreatic cancer.
Sunami Y; Kleeff J
Prog Mol Biol Transl Sci; 2019; 164():189-216. PubMed ID: 31383405
[TBL] [Abstract][Full Text] [Related]
5. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
[TBL] [Abstract][Full Text] [Related]
6. Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance.
Lee JH; Kim SK; Khawar IA; Jeong SY; Chung S; Kuh HJ
J Exp Clin Cancer Res; 2018 Jan; 37(1):4. PubMed ID: 29329547
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators.
Daoud AZ; Mulholland EJ; Cole G; McCarthy HO
BMC Cancer; 2019 Nov; 19(1):1130. PubMed ID: 31752758
[TBL] [Abstract][Full Text] [Related]
8. HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers.
Moosavi F; Giovannetti E; Saso L; Firuzi O
Crit Rev Clin Lab Sci; 2019 Dec; 56(8):533-566. PubMed ID: 31512514
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in pancreatic cancer: diagnostic, prognostic, and predictive.
Fong ZV; Winter JM
Cancer J; 2012; 18(6):530-8. PubMed ID: 23187839
[TBL] [Abstract][Full Text] [Related]
10. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
Fu Y; Liu S; Zeng S; Shen H
Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
[TBL] [Abstract][Full Text] [Related]
11. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
Das V; Kalita J; Pal M
Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
[TBL] [Abstract][Full Text] [Related]
12. Protocol of the PANCALYZE trial: a multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease.
Popp FC; Popp MC; Zhao Y; Betzler C; Kropf S; Garlipp B; Benckert C; Kalinski T; Lippert H; Bruns CJ
BMC Cancer; 2017 Mar; 17(1):229. PubMed ID: 28356064
[TBL] [Abstract][Full Text] [Related]
13. Biomaterial substrate-derived compact cellular spheroids mimicking the behavior of pancreatic cancer and microenvironment.
Wong CW; Han HW; Tien YW; Hsu SH
Biomaterials; 2019 Aug; 213():119202. PubMed ID: 31132644
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and predictive factors in pancreatic cancer.
Dell'Aquila E; Fulgenzi CAM; Minelli A; Citarella F; Stellato M; Pantano F; Russano M; Cursano MC; Napolitano A; Zeppola T; Vincenzi B; Tonini G; Santini D
Oncotarget; 2020 Mar; 11(10):924-941. PubMed ID: 32206189
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic stellate cells: what's new?
Pang TCY; Wilson JS; Apte MV
Curr Opin Gastroenterol; 2017 Sep; 33(5):366-373. PubMed ID: 28590306
[TBL] [Abstract][Full Text] [Related]
16. Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype.
Yee NS
Adv Exp Med Biol; 2013; 779():91-143. PubMed ID: 23288637
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome.
Juiz NA; Iovanna J; Dusetti N
Front Oncol; 2019; 9():246. PubMed ID: 31024848
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy and tumor microenvironment of pancreatic cancer.
Liu Q; Liao Q; Zhao Y
Cancer Cell Int; 2017; 17():68. PubMed ID: 28694739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
